No Zika vaccine for another three years: Brazil expert

March 9, 2016

Global health experts agreed Wednesday to prioritise developing vaccines against the Zika virus suspected of causing birth defects, but a Brazilian specialist warned that doing so would take at least three years.

"Perhaps in three years we will have a vaccine," Jorge Kalil, head of the Butantan Institute in Sao Paulo, told reporters in Geneva, acknowledging that even that estimate was "optimistic".

He was among experts meeting in Geneva since Monday to determine what research and development should be prioritised in the fight against Zika, which has been spreading most rapidly in the Americas.

Zika was previously only known to cause moderate cold and flu-like symptoms, but increasing evidence indicates the virus may be connected to multiple neurological disorders, as well as microcephaly, a severe birth defect in which babies are born with smaller heads and brains.

Experts have agreed that efforts should focus on developing vaccines particularly for women of child-bearing age, as well as on creating accurate diagnostic tests and innovative vector control tools to reduce mosquito populations, the World Health Organization said Wednesday.

WHO's deputy director for health systems and innovation Marie-Paule Kieny told reporters work was under way to develop an emergency vaccine "product profile" to help stake out regulatory requirements and help guide developers.

'Months from clinical trials'

She said the final profile should be ready in May, but acknowledged that developing a usable vaccine would take much longer.

"Vaccine developement is still at an early stage and the most advanced candidates are still months away from entering early human ," Kieny said.

"It is therefore possible that vaccines may come (too) late for the current Latin American outbreak," she said, stressing though that "the developement of a vaccine remains an imperative."

WHO said Wednesday that 18 companies and research institutes were currently working on Zika vaccines. None have been tested on humans.

Another 31 labs are working on developing , the global health body said, with a profile on the needed diagnostic tools expected to be ready by mid-April.

Next week, the WHO is set to convene a meeting of the world's top experts on to determine if a range of radical new methods could also be safely and efficiently used against the Aedes aegypti mosquitos carrying Zika.

Such methods could, according to experts, include releasing genetically modified mosquitos, releasing large numbers of sterilised male mosquitos to halt reproduction, or infecting mosquitos with a bacteria that prevents their eggs from hatching and reduces their ability to transmit the virus.

WHO on Tuesday advised pregnant women not to travel to areas affected by the Zika outbreak, amid mounting evidence the virus causes .

Explore further: Growing evidence linking Zika to microcephaly: WHO

Related Stories

Growing evidence linking Zika to microcephaly: WHO

February 19, 2016
The World Health Organization said Friday it could still take months to determine for certain that the Zika virus causes the serious birth defect microcephaly, but said evidence was growing.

New ways of fighting Zika needed after dengue problems

March 9, 2016
The World Health Organization says that traditional insecticide spraying has had no significant impact in slowing dengue, raising major questions about how officials might stop the spread of the Zika virus, also spread by ...

Inovio sees human trials of Zika vaccine in 2016

February 17, 2016
US biotech company Inovio Pharmaceuticals said Wednesday it has had promising test results on a Zika virus vaccine in mice and plans to launch clinical trials on humans this year.

WHO declares global health emergency over Zika situation (Update)

February 1, 2016
The World Health Organization on Monday declared that a surge in serious birth defects in South America was "strongly suspected" of being caused by the Zika virus and constituted an international health emergency.

WHO: Zika vaccines at least 18 months away from broad trials (Update)

February 12, 2016
Possible Zika vaccines are at least 18 months away from large-scale trials, the World Health Organization said Friday, while advising pregnant women to consider delaying travel to areas where the mosquito-borne virus has ...

What we know: WHO declares global emergency over Zika virus

February 1, 2016
The World Health Organization has declared a global emergency over the rapidly spreading Zika virus, which has been linked to birth defects in the Americas, saying it is an "extraordinary event" that poses a threat to the ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.